September 18, 2024Explore the transformative advancements in Alzheimer's research with expert Laurence Barker. Understand why the next decade could see significant leaps…
September 4, 2024Back to School 2024 looks at how neuroscience companies are reducing to practice the concept of human-first discovery Read the…
September 3, 2024Back to School 2024: Can biotech write a more successful playbook for translating from target to product? Read the full…
June 10, 2024If there's anyone qualified to analyze an early-stage therapeutic technology and place bets with other people's money, it's scientist-turned-venture capitalist…
April 2, 2024Even as new drugs like Eisai and Biogen’s Leqembi make a splash in Alzheimer’s, VC efforts like the Dementia Discovery…
March 26, 2024As we approach the second quarter of 2024, the SV Health Investors Partners investing out of the Dementia Discovery Fund…
February 23, 2024In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia…
February 22, 2024Dive into the fascinating world of precision neuroscience with Laurence Barker, Partner at Dementia Discovery Fund - SV Health Investors…- January 12, 2024With two new drugs emerging in 2023, could this be the year for neurodegenerative startups to shine? Read the full…
June 23, 2023In conversation with Laurence Barker, a Partner with DDF Can you give me some background on the creation of DDF…
